Latest News Archive
Please select Category, Year, and then Month to display items
06 November 2023
|
Story MBALI MABOEA
|
Photo SUPPLIED
The Department of Geography on the UFS Qwaqwa Campus recently played host to the Society of South African Geographers Conference (SSAG 2023), which gathered more than 100 students over three days.
Fostering academic growth, collaboration, and inspiration among students and researchers in the field of geography, the Department of Geography on the UFS Qwaqwa Campus recently played host to the Society of South African Geographers Conference (SSAG 2023), which gathered more than 100 students over three days.
Following a five-year hiatus, the three-day conference comprised student proposal presentations in different fields: human geography, environment geography, geoinformatics, and physical geography, divided into breakaway sessions over two days. Furthermore, day three of the annual conference included an excursion to the Basotho Cultural Village and Clarens.
The three-day annual student conference focused on different themes presented by two main speakers. The topic of the first keynote speaker, Dr Mahlomola Daemane, General Manager of the SANParks Arid Research Unit, focused on the contemporary conservation, transition, and relevance of science in policy and decision making.
The second keynote speaker was Dr Felicia Akinyemi, a Marie Sklodowska-Curie Research Fellow affiliated with the Institute of Geography at the University of Bern in Switzerland. Her work focuses on the intersection of geoinformatics, global change, and sustainability. Dr Akinyemi focused her talk on the integrative geospatial methods and metrics for sustainable land use. She introduced different techniques and metrics and gave students insight in early-career African research.
Speaking about the success of the conference, Nthebohiseng Sekhele, Geography Lecturer on the Qwaqwa Campus and chair of the organising committee, said, “The local organising committee was also very impressed with the quality of presentations from our postgraduate students in Geography, as well as the robust discussions that happened during the parallel sessions in the two days of the conference. We had a positive response of physical and online participation from many universities across South Africa. We are pleased that we have achieved our goal with this conference, which is to inspire the next generation of geographers.”
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004